Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ALNY | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 732.45 | 48.95 | 472.67 | ||
| High | 735.00 | 49.06 | 477.06 | ||
| Low | 721.22 | 48.53 | 463.03 | ||
| Latest | 722.80 | 48.57 | 465.34 | ||
| Change | -0.87 | -0.40 | -7.95 | ||
| % Change | -0.12% | -0.82% | -1.68% | ||
| Volume | 1,067,100 | 3,326,000 | 983,900 | ||
| 20-Day Average Volume | 1,154,640 | 4,439,700 | 957,085 | ||
| Previous Close | 723.67 | 48.97 | 473.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 719.07 | 47.54 | 450.85 | ||
| 20-Day Raw Stochastic | 54.59% | 78.89% | 75.71% | ||
| 20-Day Relative Strength | 59.02 | 61.01 | 54.56 | ||
| Weighted Alpha | +6.59 | +45.97 | +84.99 | ||
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.88% since 11/26/25 | +1.15% since 11/26/25 | +4.54% since 11/26/25 | ||
| Low | 720.07 on 12/03/25 | 47.13 on 12/01/25 | 444.43 on 11/28/25 | ||
| High | 788.98 on 11/28/25 | 49.31 on 12/03/25 | 479.79 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | +15.10% since 11/04/25 | +3.74% since 11/04/25 | +9.89% since 11/04/25 | ||
| Low | 628.00 on 11/05/25 | 45.81 on 11/20/25 | 417.00 on 11/05/25 | ||
| High | 790.98 on 11/26/25 | 49.31 on 12/03/25 | 479.79 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +27.43% since 09/04/25 | +22.62% since 09/04/25 | +2.60% since 09/04/25 | ||
| Low | 541.00 on 10/13/25 | 39.29 on 09/25/25 | 417.00 on 11/05/25 | ||
| High | 790.98 on 11/26/25 | 49.31 on 12/03/25 | 495.55 on 10/20/25 | ||
| 6-Month | |||||
| %Chg | +49.05% since 06/04/25 | +19.04% since 06/04/25 | +52.42% since 06/04/25 | ||
| Low | 476.49 on 06/05/25 | 35.45 on 07/17/25 | 295.82 on 06/12/25 | ||
| High | 790.98 on 11/26/25 | 49.31 on 12/03/25 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,056,984 | 99,429,368 | 62,528,232 | ||
| Shares Outstanding, K | 105,099 | 2,030,414 | 132,114 | ||
| Annual Sales | 14,202,000,000 | 40,095,390,000 | 2,248,240,000 | ||
| Annual Net Income | 4,412,600,000 | 3,290,590,000 | -278,160,000 | ||
| Last Quarter Sales | 3,754,300,000 | 11,520,500,000 | 1,249,030,000 | ||
| Last Quarter Net Income | 1,460,000,000 | 2,713,320,000 | 251,080,000 | ||
| 60-Month Beta | 0.37 | 0.45 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 11.83 on 10/28/25 | 1.48 on 10/29/25 | 2.90 on 10/30/25 | ||
| Latest Earnings Date | 10/28/25 | 10/29/25 | 10/30/25 | ||
| Most Recent Dividend | 0.880 on 11/20/25 | 0.410 on 11/14/25 | N/A | ||
| Next Ex-Dividends Date | 11/20/25 | 11/14/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.23 | 10.90 | 2,021.43 | ||